Otsuka Beijing Research Institute (OBRI) was established in 2003 as a research-based enterprise wholly owned by Otsuka Pharmaceutical Co., Ltd. of Japan, one of the world's leading comprehensive broad-based pharmaceutical companies, with a history of more than 80 years. Since its foundation, the primary focus of Otsuka Pharmaceutical’s research has bee...

Regulatory Affairs We handle the preparation of all types of registration applications for new pharmaceutical products (such as new chemical entities biological products and medical devices) and additional new indications. entrusted by the headquarters of Otsuka Pharmaceutical Co. Ltd. in Japan and Otsuka Group Companies. We also handle the submission of clinical trial applications for new ...

Home About Us Business Production Join Us Contact Us Otsuka       Otsuka Beijing Research Institute
京ICP备10032847号